Skip to content

ROCKWELL MEDICAL, INC.: 10-Q filed 2019-08-09

What ROCKWELL MEDICAL, INC. reported in its quarterly report filed 2019-08-09 (fiscal Q2 2019): 40 published measures, 98 facts as tagged in accession 0001558370-19-007774.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-09
Fiscal period
fiscal Q2 2019
Accession
0001558370-19-007774 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ROCKWELL MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-3057,076,214USD
At 2018-12-3152,557,784USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-3027,484,475USD
At 2018-12-3125,280,910USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-3029,591,739USD
At 2019-03-3120,161,047USD
At 2018-12-3127,276,874USD
At 2018-06-3016,889,239USD
At 2018-03-3127,617,150USD
At 2017-12-3132,913,148USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-06-3021,417,159USD
At 2018-12-3122,713,980USD
At 2018-06-301,748,135USD
At 2017-12-318,406,917USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-10,292,183USD91
2019-01-01 to 2019-06-30-18,970,530USD181
2018-04-01 to 2018-06-30-12,230,792USD91
2018-01-01 to 2018-06-30-17,780,313USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-15,778,417USD181
2018-01-01 to 2018-06-30-9,856,940USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-3018,262,358USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-3,780,762USD181
2018-01-01 to 2018-06-303,198,158USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-291,358,764USD
At 2018-12-31-272,388,234USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-06-302,563,428USD
At 2018-12-312,638,293USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-06-303,018,628USD181
2018-01-01 to 2018-06-301,811,335USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-10,370,794USD91
2019-01-01 to 2019-06-30-19,180,555USD181
2018-04-01 to 2018-06-30-12,296,903USD91
2018-01-01 to 2018-06-30-18,015,707USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-3048,262,338USD
At 2018-12-3146,825,230USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-3014,834,588USD
At 2018-12-3113,204,511USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-06-304,065,302USD
At 2018-12-314,492,071USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2019-06-30920,745USD
At 2018-12-31920,745USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-06-305,388,858USD
At 2018-12-316,979,514USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-06-303,972,637USD
At 2018-12-314,038,778USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-30733,149USD91
2019-01-01 to 2019-06-301,743,541USD181
2018-04-01 to 2018-06-30-4,017,008USD91
2018-01-01 to 2018-06-30-4,737,499USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-04-01 to 2019-06-302,958,276USD91
2019-01-01 to 2019-06-303,455,552USD181
2018-04-01 to 2018-06-301,558,946USD91
2018-01-01 to 2018-06-303,225,302USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-3063,398,704shares
At 2018-12-3157,034,154shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-06-3067,557USD
At 2018-12-3163,148USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-06-303,329,481USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-06-303,327,791USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2019-06-308,185,648USD
At 2018-12-318,859,432USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-06-305,622,220USD
At 2018-12-316,221,139USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-06-30555,222USD
At 2018-12-31536,516USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-06-304,071,341USD
At 2018-12-315,129,761USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-06-303,667,605USD
At 2018-12-311,903,682USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2019-06-302,243,256USD
At 2018-12-312,252,868USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-10,280,521USD91
2019-01-01 to 2019-06-30-18,966,121USD181
2018-04-01 to 2018-06-30-12,093,243USD91
2018-01-01 to 2018-06-30-17,835,244USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-305,496,670USD91
2019-01-01 to 2019-06-3011,717,169USD181
2018-04-01 to 2018-06-305,526,575USD91
2018-01-01 to 2018-06-308,643,449USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-04-01 to 2019-06-30200,000USD91
2019-01-01 to 2019-06-30400,000USD181
2018-04-01 to 2018-06-30200,000USD91
2018-01-01 to 2018-06-30300,000USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-01-01 to 2019-06-30380,372USD181
2018-01-01 to 2018-06-30281,327USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-04-01 to 2019-06-3078,611USD91
2019-01-01 to 2019-06-30210,025USD181
2018-04-01 to 2018-06-3066,111USD91
2018-01-01 to 2018-06-30235,394USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-04-01 to 2019-04-302,296,235USD30

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2019-04-01 to 2019-06-30514,116USD91
2019-01-01 to 2019-06-301,038,081USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-1,590,656USD181
2018-01-01 to 2018-06-30-1,001,160USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-66,141USD181
2018-01-01 to 2018-06-30-1,310,702USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-426,772USD181
2018-01-01 to 2018-06-30-1,015,539USD181

Inspect the source

Entity
ROCKWELL MEDICAL, INC. / CIK 0001041024
Captured
2026-09-20T05:15:52.429Z
SEC response SHA-256
88e8b83e4e95fda016bcc9a5dced4522c975c40fff65ebdbda5ac42b28ba4fb6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001041024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))